Innogen · News · February 22, 2013

Innogen Weekly News Roundup (16/02/13 - 22/02/13)

Innogen Weekly News Roundup (16/02/13 - 22/02/13)

All the latest news from around the world on the life sciences and emerging technologies.

A weekly roundup of global news on topics, including: agriculture, the bioeconomy, food and energy security, genes and genomics, global health and development, healthcare, innovation systems, pharma, synthetic biology, science and technology.


Farmer’s Supreme Court Challenge Puts Monsanto Patents at Risk (New York Times)

Food science expert: Genetically modified crops are overregulated (e! Science News)

Developing world boost for GM crops (Financial Times)

Developing countries plant most GM crops (Farmers Guardian)


Biotech & Pharma Whining About Talent: That Makes Me Mad (Xconomy)

European Commission establishing bioeconomy observatory (BioBased Digest)


Can They Patent Your Genes? (The New York Review of Books)

Firm wins right to breast cancer gene patent in Australia, ahead of US case (Wired)

Global Health

MamaYe launches website to promote maternal health in Ghana (BusinessGhana)

Big Data, Better Global Health (Council on Foreign Relations)


Families Push for New Ways to Research Rare Diseases (The Wall Street Journal)

Regenerative medicine “The best market in the world right now” (The Economist)


Study finds that ‘Big Pharma’ fails at self-policing ED drug advertising (EurekAlert!)

Biosimilars to replace 70% of chemical drugs (GaBI Online)

There’s Nothing Contradictory About Amgen’s Biosimilars Move (Forbes)

GSK Pharma: Price control may prove costly for company (Economic Times)

Pharmaceutical Innovation In UK Not Dying (Science 2.0)

Fixing a Broken Drug Business by Spreading the Wealth (Wired)

Science & Technology

Scientists create ‘sixth sense’ brain implant to detect infrared light (Telegraph)

The top 10 emerging technologies for 2013 (World Economic Forum)

When Mutant Mosquitoes Attack (The New York Times)

Synthetic Biology

Synthesizing DNA 10,000 times cheaper and making a synthetic biology revolution (Next Big Future)

The “new frontier” of synthetic biology (Scope)